This grant, offered by the CDC, aims to enhance Central Asia’s capacity to deliver high-quality HIV/AIDS prevention, treatment, laboratory, and strategic information programs. The core purpose is to achieve HIV epidemic control by 2030, adhering to international standards while being locally adapted. This initiative seeks to leverage investments from PEPFAR’s strategic framework to build resilient health systems capable of responding effectively to public health threats. Key focus areas include expanding access to evidence-based HIV prevention services like PrEP and MAT, improving treatment continuity to meet 95-95-95 targets, strengthening data utilization for program impact, and enhancing public health security preparedness. The grant also emphasizes ensuring sustained, resilient programs and fostering coordination with stakeholders for policy and implementation.
Opportunity ID: 350449
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0069 |
Funding Opportunity Title: | Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Dec 20, 2023 |
Last Updated Date: | Jan 10, 2024 |
Original Closing Date for Applications: | Mar 04, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Current Closing Date for Applications: | Mar 04, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Apr 11, 2024 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,200,000 for Year 1, subject to the availability of funds.This NOFO aims to enhance Central Asia’s capacity to provide high-quality HIV/AIDS prevention, treatment, laboratory, and strategic information (SI) programs. The goal is to achieve epidemic control by 2030, following international standards (e.g., UNAIDS, International Health Regulations), and adapted to the local context. Based on PEPFAR’s 5×3 Strategic Framework (September 2022), the focus is on leveraging investments to build resilient health systems that can effectively respond to public health threats. Key areas of focus include:Establishing access to evidence-based HIV prevention services such as case-finding, client-centric referral, pre-exposure prophylaxis (PrEP), and Medication-Assisted Therapy (MAT) services;Improving client-centric HIV treatment continuity to achieve 95-95-95 and address related co-morbidities through enhanced patient management, monitoring, laboratory capacity, care, treatment, and patient satisfaction;Strengthening capacity for collecting, managing, and utilizing SI to inform program implementation and impact assessment;Enhancing the health system’s ability to strengthen public health security, preparedness, and response;Ensuring sustained, resilient public health programs at individual, facility, and organizational levels to achieve HIV/AIDS epidemic control; andCoordinating with key community and relevant stakeholders for evidence-based policy development, sustained program design, financing, and implementation. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
pepfarfoas@cdc.gov Email:pepfarfoas@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Q&A amendment | Jan 10, 2024 | |
Dec 20, 2023 | ||
Forwarded to queue. | Oct 03, 2023 | |
Forwarded to queue. | Oct 03, 2023 | |
Oct 03, 2023 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0069 |
Funding Opportunity Title: | Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Dec 20, 2023 |
Last Updated Date: | Jan 10, 2024 |
Original Closing Date for Applications: | Mar 04, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Current Closing Date for Applications: | Mar 04, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Apr 11, 2024 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,200,000 for Year 1, subject to the availability of funds.This NOFO aims to enhance Central Asia’s capacity to provide high-quality HIV/AIDS prevention, treatment, laboratory, and strategic information (SI) programs. The goal is to achieve epidemic control by 2030, following international standards (e.g., UNAIDS, International Health Regulations), and adapted to the local context. Based on PEPFAR’s 5×3 Strategic Framework (September 2022), the focus is on leveraging investments to build resilient health systems that can effectively respond to public health threats. Key areas of focus include:Establishing access to evidence-based HIV prevention services such as case-finding, client-centric referral, pre-exposure prophylaxis (PrEP), and Medication-Assisted Therapy (MAT) services;Improving client-centric HIV treatment continuity to achieve 95-95-95 and address related co-morbidities through enhanced patient management, monitoring, laboratory capacity, care, treatment, and patient satisfaction;Strengthening capacity for collecting, managing, and utilizing SI to inform program implementation and impact assessment;Enhancing the health system’s ability to strengthen public health security, preparedness, and response;Ensuring sustained, resilient public health programs at individual, facility, and organizational levels to achieve HIV/AIDS epidemic control; andCoordinating with key community and relevant stakeholders for evidence-based policy development, sustained program design, financing, and implementation. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
pepfarfoas@cdc.gov Email:pepfarfoas@cdc.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0069 |
Funding Opportunity Title: | Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 20, 2023 |
Last Updated Date: | Dec 20, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Mar 04, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Feb 24, 2025 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,200,000 for Year 1, subject to the availability of funds.This NOFO aims to enhance Central Asia’s capacity to provide high-quality HIV/AIDS prevention, treatment, laboratory, and strategic information (SI) programs. The goal is to achieve epidemic control by 2030, following international standards (e.g., UNAIDS, International Health Regulations), and adapted to the local context. Based on PEPFAR’s 5×3 Strategic Framework (September 2022), the focus is on leveraging investments to build resilient health systems that can effectively respond to public health threats. Key areas of focus include:Establishing access to evidence-based HIV prevention services such as case-finding, client-centric referral, pre-exposure prophylaxis (PrEP), and Medication-Assisted Therapy (MAT) services;Improving client-centric HIV treatment continuity to achieve 95-95-95 and address related co-morbidities through enhanced patient management, monitoring, laboratory capacity, care, treatment, and patient satisfaction;Strengthening capacity for collecting, managing, and utilizing SI to inform program implementation and impact assessment;Enhancing the health system’s ability to strengthen public health security, preparedness, and response;Ensuring sustained, resilient public health programs at individual, facility, and organizational levels to achieve HIV/AIDS epidemic control; andCoordinating with key community and relevant stakeholders for evidence-based policy development, sustained program design, financing, and implementation. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
pepfarfoas@cdc.gov Email:pepfarfoas@cdc.gov |
DISPLAYING: Forecast 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0069 |
Funding Opportunity Title: | Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 3 |
Posted Date: | Oct 03, 2023 |
Last Updated Date: | Dec 14, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | Feb 24, 2025 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,200,000 for Year 1, subject to the availability of funds.This NOFO aims to enhance Central Asia’s capacity to provide high-quality HIV/AIDS prevention, treatment, laboratory, and strategic information (SI) programs. The goal is to achieve epidemic control by 2030, following international standards (e.g., UNAIDS, International Health Regulations), and adapted to the local context. Based on PEPFAR’s 5×3 Strategic Framework (September 2022), the focus is on leveraging investments to build resilient health systems that can effectively respond to public health threats. Key areas of focus include:Establishing access to evidence-based HIV prevention services such as case-finding, client-centric referral, pre-exposure prophylaxis (PrEP), and Medication-Assisted Therapy (MAT) services;Improving client-centric HIV treatment continuity to achieve 95-95-95 and address related co-morbidities through enhanced patient management, monitoring, laboratory capacity, care, treatment, and patient satisfaction;Strengthening capacity for collecting, managing, and utilizing SI to inform program implementation and impact assessment;Enhancing the health system’s ability to strengthen public health security, preparedness, and response;Ensuring sustained, resilient public health programs at individual, facility, and organizational levels to achieve HIV/AIDS epidemic control; andCoordinating with key community and relevant stakeholders for evidence-based policy development, sustained program design, financing, and implementation. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:pepfarfoas@cdc.gov |
DISPLAYING: Forecast 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0069 |
Funding Opportunity Title: | Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 2 |
Posted Date: | Oct 03, 2023 |
Last Updated Date: | Dec 14, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | Feb 24, 2025 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,200,000 for Year 1, subject to the availability of funds.This NOFO aims to enhance Central Asia’s capacity to provide high-quality HIV/AIDS prevention, treatment, laboratory, and strategic information (SI) programs. The goal is to achieve epidemic control by 2030, following international standards (e.g., UNAIDS, International Health Regulations), and adapted to the local context. Based on PEPFAR’s 5×3 Strategic Framework (September 2022), the focus is on leveraging investments to build resilient health systems that can effectively respond to public health threats. Key areas of focus include:Establishing access to evidence-based HIV prevention services such as case-finding, client-centric referral, pre-exposure prophylaxis (PrEP), and Medication-Assisted Therapy (MAT) services;Improving client-centric HIV treatment continuity to achieve 95-95-95 and address related co-morbidities through enhanced patient management, monitoring, laboratory capacity, care, treatment, and patient satisfaction;Strengthening capacity for collecting, managing, and utilizing SI to inform program implementation and impact assessment;Enhancing the health system’s ability to strengthen public health security, preparedness, and response;Ensuring sustained, resilient public health programs at individual, facility, and organizational levels to achieve HIV/AIDS epidemic control; andCoordinating with key community and relevant stakeholders for evidence-based policy development, sustained program design, financing, and implementation. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:pepfarfoas@cdc.gov |
DISPLAYING: Forecast 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0069 |
Funding Opportunity Title: | Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 1 |
Posted Date: | Oct 03, 2023 |
Last Updated Date: | Oct 03, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | Feb 24, 2025 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,200,000 for Year 1, subject to the availability of funds.This NOFO aims to enhance Central Asia’s capacity to provide high-quality HIV/AIDS prevention, treatment, laboratory, and strategic information (SI) programs. The goal is to achieve epidemic control by 2030, following international standards (e.g., UNAIDS, International Health Regulations), and adapted to the local context. Based on PEPFAR’s 5×3 Strategic Framework (September 2022), the focus is on leveraging investments to build resilient health systems that can effectively respond to public health threats. Key areas of focus include:Establishing access to evidence-based HIV prevention services such as case-finding, client-centric referral, pre-exposure prophylaxis (PrEP), and Medication-Assisted Therapy (MAT) services;Improving client-centric HIV treatment continuity to achieve 95-95-95 and address related co-morbidities through enhanced patient management, monitoring, laboratory capacity, care, treatment, and patient satisfaction;Strengthening capacity for collecting, managing, and utilizing SI to inform program implementation and impact assessment;Enhancing the health system’s ability to strengthen public health security, preparedness, and response;Ensuring sustained, resilient public health programs at individual, facility, and organizational levels to achieve HIV/AIDS epidemic control; andCoordinating with key community and relevant stakeholders for evidence-based policy development, sustained program design, financing, and implementation. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:pepfarfoas@cdc.gov |
Related Documents
Folder 350449 Full Announcement-Full Announcement -> full NOFO Foa_Content_of_CDC-RFA-GH-24-0069.pdf
Folder 350449 Revised Full Announcement-Revised Full Announcement -> Revised Foa_Content_of_CDC-RFA-GH-24-0069 (1).pdf
Packages
Agency Contact Information: | Emily Dale pepfarfoas@cdc.gov Email: pepfarfoas@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.067 | CDC-RFA-GH-24-0069 | Strengthening Capacity of Central Asia and Eastern Europe Countries to Implement Sustainable and Effective HIV/AIDS Prevention, Care, and Treatment and Health Security Programs under PEPFAR | PKG00284248 | Jan 10, 2024 | Mar 04, 2024 | View |
Package 1
Mandatory forms
350449 SF424_4_0-4.0.pdf
350449 Project_AbstractSummary_2_0-2.0.pdf
350449 SFLLL_2_0-2.0.pdf
350449 SF424A-1.0.pdf
350449 BudgetNarrativeAttachments_1_2-1.2.pdf
350449 ProjectNarrativeAttachments_1_2-1.2.pdf
Optional forms
350449 OtherNarrativeAttachments_1_2-1.2.pdf